108 related articles for article (PubMed ID: 32360010)
1. The Renin-Angiotensin-Aldosterone System in Coronavirus Infection-Current Considerations During the Pandemic.
Augoustides JGT
J Cardiothorac Vasc Anesth; 2020 Jul; 34(7):1717-1719. PubMed ID: 32360010
[No Abstract] [Full Text] [Related]
2. Renin-Angiotensin System Blockade and Mortality in Patients With Hypertension and COVID-19 Infection.
Salah HM; Calcaterra G; Mehta JL
J Cardiovasc Pharmacol Ther; 2020 Nov; 25(6):503-507. PubMed ID: 32748634
[TBL] [Abstract][Full Text] [Related]
3. [Renin-angiotensin system blockers and COVID-19 infection].
Ruilope LM; Garcia Donaire JA; de la Sierra A
Hipertens Riesgo Vasc; 2020; 37(3):99-100. PubMed ID: 32448641
[No Abstract] [Full Text] [Related]
4. Clinical characteristics of coronavirus disease 2019 (COVID-19) patients with hypertension on renin-angiotensin system inhibitors.
Zhou X; Zhu J; Xu T
Clin Exp Hypertens; 2020 Oct; 42(7):656-660. PubMed ID: 32404011
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular Damage in COVID-19: Therapeutic Approaches Targeting the Renin-Angiotensin-Aldosterone System.
Lumpuy-Castillo J; Lorenzo-Almorós A; Pello-Lázaro AM; Sánchez-Ferrer C; Egido J; Tuñón J; Peiró C; Lorenzo Ó
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899833
[TBL] [Abstract][Full Text] [Related]
6. In reply-Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers.
Sanchis-Gomar F; Lavie CJ; Perez-Quilis C; Henry BM; Lippi G
Mayo Clin Proc; 2020 Jul; 95(7):1553-1556. PubMed ID: 32622458
[No Abstract] [Full Text] [Related]
7. Angiotensin-converting enzyme 2 as a versatile player in the management of coronavirus disease 2019.
Amano T
J Diabetes Investig; 2020 Sep; 11(5):1120-1122. PubMed ID: 32657484
[No Abstract] [Full Text] [Related]
8. Covid-19 and the Renin Angiotensin System: Implications for the Older Adults.
Bahat G
J Nutr Health Aging; 2020; 24(7):699-704. PubMed ID: 32744564
[No Abstract] [Full Text] [Related]
9. Interactions between antihyperglycemic drugs and the renin-angiotensin system: Putative roles in COVID-19. A mini-review.
Nakhleh A; Shehadeh N
Diabetes Metab Syndr; 2020; 14(4):509-512. PubMed ID: 32388330
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 and RAS: Unravelling an Unclear Relationship.
D'Ardes D; Boccatonda A; Rossi I; Guagnano MT; Santilli F; Cipollone F; Bucci M
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32344526
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 Illness and Heart Failure: A Missing Link?
Mehra MR; Ruschitzka F
JACC Heart Fail; 2020 Jun; 8(6):512-514. PubMed ID: 32360242
[No Abstract] [Full Text] [Related]
12. Angiotensin converting enzyme inhibitors do not increase the risk of poor outcomes in COVID-19 disease. A multi-centre observational study.
Khan KS; Reed-Embleton H; Lewis J; Bain P; Mahmud S
Scott Med J; 2020 Nov; 65(4):149-153. PubMed ID: 32873147
[TBL] [Abstract][Full Text] [Related]
13. Reply to Siniorakis et al., "COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure".
Fedson DS; Opal SM; Rordam OM
mBio; 2020 May; 11(3):. PubMed ID: 32471831
[No Abstract] [Full Text] [Related]
14. COVID-19 and cardiovascular comorbidities: An update.
Teixeira R; Santos M; Gil V
Rev Port Cardiol (Engl Ed); 2020 Aug; 39(8):417-419. PubMed ID: 32718858
[No Abstract] [Full Text] [Related]
15. Response by Zhang et al to Letter Regarding Article, "Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19".
Zhang P; Zhu L; Cai J; Lei F; Qin JJ; Wang Y; Yuan Y; Rohit L; Liu PP; Li H
Circ Res; 2020 Jun; 126(12):e142-e143. PubMed ID: 32496914
[No Abstract] [Full Text] [Related]
16. Electrolyte Disturbances in SARS-CoV-2 Infection.
Mabillard H; Sayer JA
F1000Res; 2020; 9():587. PubMed ID: 33093945
[TBL] [Abstract][Full Text] [Related]
17. Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: A novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis.
Henry BM; Vikse J; Benoit S; Favaloro EJ; Lippi G
Clin Chim Acta; 2020 Aug; 507():167-173. PubMed ID: 32348783
[TBL] [Abstract][Full Text] [Related]
18. Evaluating sources of bias in observational studies of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker use during COVID-19: beyond confounding.
Cohen JB; D'Agostino McGowan L; Jensen ET; Rigdon J; South AM
J Hypertens; 2021 Apr; 39(4):795-805. PubMed ID: 33186321
[TBL] [Abstract][Full Text] [Related]
19. An Immediate and Long-Term Complication of COVID-19 May Be Type 2 Diabetes Mellitus: The Central Role of β-Cell Dysfunction, Apoptosis and Exploration of Possible Mechanisms.
Hayden MR
Cells; 2020 Nov; 9(11):. PubMed ID: 33202960
[TBL] [Abstract][Full Text] [Related]
20. Recommendations for the management of hyperkalemia in patients receiving renin-angiotensin-aldosterone system inhibitors: comment.
Özdede M; Güven AT
Intern Emerg Med; 2024 Apr; 19(3):879-881. PubMed ID: 38170421
[No Abstract] [Full Text] [Related]
[Next] [New Search]
